Prednisone Articles
Genelabs hopes for GL701 decision in 2001
2 June 2000
Genelabs to file for US approval of lupus drug, first in 40 years
15 February 2000
R-PR gets FDA panel OK for Taxotere use
15 December 1999
Genentech and IDEC seek to broaden NHL indications for Rituxan
8 December 1999
AHP weathers the storm with first Rapamune approval
17 September 1999
B-MS' Taxol improves survival in breast cancer
6 August 1999
FDA panel backs Wyeth's Rapamune
28 July 1999
Vertex' MDR Inhibitor Incel
29 July 1998
AHP's Rapamune Improves 6-Month Graft Survival
16 July 1998
Clinical Trial News In Brief
28 May 1998
Agouron Starts Pivotal Trials Of AG3340
7 May 1998
Coulter Pharmaceutical On Road To Success
19 March 1998
FDA Panel Backs New Use For Intron A
23 October 1997
Roche's Zenapax Gets Backing Of FDA Panel
23 October 1997
FDA Panel Votes Against Approving J&J's Liazal
26 June 1997
Genelabs' Stock Drops As Lupus Drug Stalls
5 May 1997
Six-Month Zenapax Data; Global Filing Set For 1H97
24 February 1997
IDEC Non-Hodgkin's Lymphoma Antibody Clears Phase III Trials
16 December 1996
Zenapax Results Boost PDL And Roche
7 October 1996
2nd Trial For Lupus Treatment
15 April 1996
Phase II Study of IDEC Anticancer Antibody
13 November 1995
Sandoz MDR Drug Shows Promise In Early Trials
13 November 1995
First Approval For Roche's Mycophenolate Mofetil
15 May 1995
CICLOSPORIN'S ROLE IN BOWEL INFLAMMATION
4 July 1994
MYOTROPHIN TESTED FOR POST-POLIO SYNDROME
16 May 1994
B-MS' VUMON APPROVED IN USA
3 August 1992
THAMIDOMIDE AS AN IMMUNOSUPPRESSANT
27 April 1992
CORTICOSTEROIDS AND OPTIC NEURITIS
9 March 1992
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
